Mylan exits Biocon, PC Jeweller QIP, Aurum buys Housing.com
Biocon's ₹4,000 cr overhang, PC Jeweller's ₹1,000 cr QIP, Aurum's Housing.com acquisition lead; mid-cap demerger and small-cap defence order add depth.
| Index | Level | Move |
|---|---|---|
| Bank Nifty | 56,755.60 | -0.58% |
| Nifty Auto | 27,843.90 | 0.00% |
| Nifty Energy | 38,174.80 | 0.00% |
| Nifty Financial Services | 28,497.30 | 0.00% |
| Nifty FMCG | 48,881.20 | 0.00% |
| Nifty Healthcare | 16,497.70 | 0.00% |
| Nifty IT | 30,418.35 | +3.32% |
| Nifty Media | 1,558.60 | 0.00% |
| Nifty Metal | 12,400.25 | 0.00% |
| Nifty Pharma | 25,998.85 | +0.20% |
| Nifty Private Bank | 16,648.10 | +2.00% |
| Nifty PSU Bank | 8,284.20 | 0.00% |
| Nifty Realty | 921.45 | 0.00% |
| Nifty Cement | 15,276.60 | 0.00% |
| Nifty Chemicals | 30,047.25 | 0.00% |
| Nifty Consumer Durables | 39,550.80 | 0.00% |
| Nifty Oil & Gas | 11,067.85 | 0.00% |
- Large-cap pharma: Biocon's stake sale overhang dominates, despite being a secondary event.
- Mid-cap consumer/materials: PC Jeweller QIP and India Glycols demerger show deleveraging and value unlock.
- Small-cap tech: Aurum's Housing.com deal changes the company completely but dilutes heavily.
- Small-cap defence: PTC's BrahMos order marks a strategic pivot worth watching.
- Micro-cap governance: Jyoti Structures' leadership vacuum, Keerthi's IBC notice, and Ansal Buildwell's subsidiary revival flags risk and recovery stories.
Biocon Ltd.
Biocon's long-standing biosimilar partner Mylan sold its entire 5.64% stake in a ₹4,000 cr open-market sale. The exit signals a potential change in the partnership dynamic and adds a large supply overhang for a stock already trading at a trailing P/E of 174.9 with just 4.7% ROE. For a company with revenue growth of only 2.25% and PAT declining 56.8%, the strategic read-through is more concerning than the block itself.
- ₹4,000 cr
- Value of Mylan's entire 5.64%
- ₹67,454 cr
- Large cap mcap
- 174.93x
- P/E
- -56.77%
- PAT
- +2.25%
- Rev
- 0.82x
- D/E
PC Jeweller Ltd.
PC Jeweller's board cleared a ₹1,000 cr QIP, about 12% of its market cap. The capital comes after the company repaid over 90% of debt and settled a 13-year customs case, shifting from deleveraging to growth mode. The pricing of the QIP will determine near-term sentiment, but the move is justified by a 32.7% revenue growth and improving ROE trajectory.
- ₹1,000 cr
- Qualified institutions placement
- ₹8,322 cr
- Mid cap mcap
- 11.65x
- P/E
- +61.31%
- PAT
- +32.66%
- Rev
- 0.33x
- D/E
Aurum Proptech Ltd.
Aurum PropTech is acquiring Housing.com for ₹458 cr in an all-share deal. Housing.com's ₹687 cr FY25 revenue dwarfs Aurum's own scale, making this a large but heavily dilutive transaction. Promoter warrants signal confidence, but integration risk is high for a small-cap with a P/E of 868x and near-zero ROE.
- ₹458 cr
- Acquisition cost for Housing.com,
- ₹1,651 cr
- Small cap mcap
- +285.31%
- PAT
- +82.8%
- Rev
- 0.3x
- D/E
AYE Finance Ltd.
AYE Finance plans a ₹4,000 cr NCD issuance, nearly its entire market cap of ₹4,144 cr. For a small-cap NBFC with debt/equity of 2.73 and AUM growth of 28%, this aggressive balance-sheet expansion tests the cost of capital and asset quality. The raise signals confidence in growth but adds use risk if loan performance weakens.
- ₹4,000 cr
- Proposed NCD issuance, ~96% of
- ₹4,144 cr
- Small cap mcap
- 21.4x
- P/E
- +111.08%
- PAT
- +29.16%
- Rev
- 2.73x
- D/E
India Glycols Ltd.
India Glycols received NCLT approval for its three-way demerger, removing a major legal overhang. The split will create pure-play entities in bio-pharma and spirits, potentially unlocking sum-of-parts value. For a mid-cap with a P/E of 21.9 and 40% PAT growth, the demerger clarifies the investment thesis.
- ₹6,404 cr
- India Glycols' Mkt cap ahead of
- ₹6,404 cr
- Mid cap mcap
- 21.87x
- P/E
- +40.39%
- PAT
- +7.83%
- Rev
- 0.8x
- D/E
PTC Industries Ltd.
PTC Industries has landed a BrahMos missile sub-systems order, marking its entry into systems integration. The undisclosed value is secondary to the strategic shift from precision components to higher-barrier integrated sub-systems. For a company with 84.9% revenue growth and a 257x P/E, the order validates its 'Melt to Mission' capability and opens a larger addressable market.
- Undisclosed (2-year programme)
- BrahMos missile sub-systems order
- ₹26,132 cr
- Large cap mcap
- +143.81%
- PAT
- +84.93%
- Rev
- 0.04x
- D/E
RSC International Ltd.
RSC International, a shell with zero revenue and negative net worth, is acquiring 51% of fintech FA Wizard for ₹20.69 cr via share swap. FA Wizard's provisional FY26 revenue of ₹155 cr is over nine times RSC's market cap, making this a complete business transformation. Existing shareholders face severe dilution but gain exposure to a high-growth fintech.
- ₹20.69 crore
- Acquisition consideration for 51%
- ₹17.39 cr
- Micro cap mcap
- +86.8%
- PAT
- 0.43x
- D/E
Harmony Capital Services Ltd.
Harmony Capital, a non-operating shell absorbing engineering firm Truvolt in a share-swap deal valued at ₹83.47 cr, is a de facto reverse merger. The issuance will more than tenfold the share count, severely diluting existing holders. For a shell with a ₹113 cr market cap, the transaction redefines the investment thesis but at a steep cost to current shareholders.
- ₹83.47 cr
- Consideration equals 70% of
- ₹113 cr
- Micro cap mcap
- +279.79%
- PAT
- 0x
- D/E
Jyoti Structures Ltd.
Jyoti Structures has lost both its Chairman and CEO within two months, with no succession plan announced. For a small-cap with a debt/equity of 3.55 and a market cap of ₹1,394 cr, a leadership vacuum creates strategic drift and unsettles creditors. The board must name successors quickly to avoid derailing the operational recovery.
- ₹1,394 cr
- Mkt cap; both Chairman and CEO
- ₹1,394 cr
- Small cap mcap
- 24.88x
- P/E
- +52.05%
- PAT
- +42.25%
- Rev
- 3.55x
- D/E
Wanbury Ltd.
Wanbury redeemed ₹180 cr of NCDs five years early, eliminating debt equal to about 15% of its market cap. This signals improved liquidity and management's confidence in cash flows, a significant positive surprise for a micro-cap pharma firm. The move reduces interest costs and financial risk, strengthening the balance sheet.
- ₹180 crore
- Outstanding principal of NCDs
- ₹959 cr
- Micro cap mcap
- 22.3x
- P/E
- +7.15%
- PAT
- -4.31%
- Rev
- 2.92x
- D/E
Kalyani Steels Ltd.
Kalyani Steels reopened its Ginigera plant just four days after the CPCB ordered its closure. The quick resolution removes a potential prolonged disruption for a company with trailing revenue declining 11%. The plant's return normalizes output, but compliance conditions remain.
- 4 days
- Duration of plant shutdown from
- ₹3,574 cr
- Small cap mcap
- 13.86x
- P/E
- -10.63%
- PAT
- -11.01%
- Rev
- 0.23x
- D/E
Tatva Chintan Pharma Chem Ltd.
Tatva Chintan is investing ₹200 cr in a greenfield expansion at Dahej-III, about 40% of its annual revenue, and raising its borrowing limit to ₹1,000 cr. For a nearly debt-free small-cap, this capex signals a major strategic shift. Execution risk is high given the 21-month timeline and a stock trading at 65.7x P/E.
- ₹200 cr
- Greenfield expansion at
- ₹2,762 cr
- Small cap mcap
- 65.68x
- P/E
- +902.04%
- PAT
- +24.36%
- Rev
- 0.05x
- D/E
Keerthi Industries Ltd.
Keerthi Industries faces an IBC notice over a ₹4.31 cr coal bill, roughly 14% of its equity value. For a cement micro-cap already reporting a ₹15 cr net loss and a plant shutdown, this formalizes default risk and could escalate to insolvency. The notice compounds severe liquidity stress.
- ₹4.31 cr
- Operational debt claimed by coal
- ₹30.46 cr
- Micro cap mcap
- +55.79%
- PAT
- +39.1%
- Rev
- 1.42x
- D/E
Ansal Buildwell Ltd.
NCLT approved the revival of Ansal Buildwell's subsidiary Ansal Crown, ending a ₹58.9 cr contingent liability that exceeded the parent's market cap of ₹63.6 cr. While the resolution removes the overhang, equity is likely wiped out at the subsidiary level. The parent's valuation now depends entirely on its struggling standalone business.
- ₹58.9 cr
- Contingent exposure to
- ₹63.6 cr
- Micro cap mcap
- 78.72x
- P/E
- -195.3%
- PAT
- -13.81%
- Rev
- 0.29x
- D/E
-
JSW Steel dropped its 50% captive coking coal target by FY31 without explanation, now guiding for only ~30% by CY2028. The retreat, unacknowledged in the Q1 call, undermines credibility on raw material strategy.
JSWSTEEL concall note -
South Indian Bank reversed its stated priority to reduce corporate loans to 30-33% of advances, growing the book to 40% and calling it a 'one-time adjustment'. The u-turn mars the NIM recovery story and raises questions about strategic consistency.
SOUTHBANK concall note -
Borosil Renewables halved its first-year rooftop solar revenue target from ₹75 crore to ₹36 crore. The 600 TPD expansion revenue was also pushed to FY28. While core glass margins are strong, the pivot is off to a slow start.
BORORENEW concall note
-
Federal Bank's CASA ratio jumped to 32.2%, driving a 13 bps sequential NIM expansion. Credit cost came in at 41 bps, but management held 50-60 bps guidance citing macro risks—caution overrides near-term comfort.
FEDERALBNK concall note -
JSW Steel's Q1 was strong with 20% EBITDA margin, but the unacknowledged retreat on captive coal target and BF3 delay are the real story. The credibility hit on raw material strategy overshadows operational beat.
JSWSTEEL concall note -
Hexagon Nutrition's maiden earnings call showed EBITDA margin jumping to 13.83% as branded sales grow. The clinical nutrition TAM of ₹6,300 cr offers a long-term growth opportunity, but growing the branded share will determine the multiple.
HEXAGON concall note -
South Indian Bank's NIM recovery is real, but the corporate book u-turn mars the strategy story. Management opportunistically grew corporate loans to 40% against a prior target of 30-33%, without reaffirming the medium-term goal.
SOUTHBANK concall note -
Borosil Renewables' core glass business is shining with 35% EBITDA margins, but the rooftop solar pivot is off to a slow start with a halved revenue target. Expansion revenue is a year away, leaving near-term growth dependent on core glass.
BORORENEW concall note -
Heritage Foods' ice cream facility hit 40% utilization, the low end of its own 40-45% guidance. While Q1 revenue was record, milk volumes remained flat and the mini flush failed—guided milestones are slipping.
HERITGFOOD concall note -
Ceat's gross margin sank 575 bps QoQ to 33.9% despite 11% price hikes, as rubber costs surged. Management vows to hold prices until 40-41% margins return, but Q2 raw material costs are locked at elevated levels.
CEATLTD concall note
- EU · Inflation (Final) Jun: actual 2.77% YoY vs prev 3.18% — eases pressure on ECB.
- IN · FX Reserves: prev $674.19 bn, actual $675.16 bn — steady.
- IN · Current Account Balance Q1: prev -1.29% of GDP — data due.
- IN · Railway Freight: monthly data — impact low.
- IN · Broad Money Supply (M3): prev 12.95% YoY — monitoring liquidity.